| J9271 | Injection, pembrolizumab, 1 mg | 7,800 | $40 | $343.2K |
| J0897 | Injection, denosumab, 1 mg | 11,520 | $20 | $218.9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 1,230 | $130 | $155.4K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,950 | $20 | $56K |
| Q5123 | Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | 1,220 | $30 | $41.4K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 2,500 | $20 | $40K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 1,560 | $20 | $28.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 220 | $100 | $21.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 210 | $90 | $18.6K |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 210 | $70 | $14.4K |